Newsroom

Blueprint Medicines Announces Top-line Results from Phase 3 VOYAGER Trial

Blueprint Medicines Announces Top-line Results from Phase 3 VOYAGER Trial of Avapritinib versus Regorafenib in Patients with Advanced Gastrointestinal Stromal Tumor in patients with locally advanced unresectable or metastatic gastrointestinal stromal tumor (GIST).

By |2020-04-28T13:52:38-04:00April 28th, 2020|News|

Conversations with the Life Raft Group LIVE

Conversations with the Life Raft Group will debuted 4/2/2020 at 1 pm. Our first featured guest was Norman J. Scherzer, the Executive Director of the Life Raft Group. With his background at the CDC as Assistant Commissioner of Health for NYC, Norman is an excellent resource for discussing strategies for coping with COVID-19.

By |2020-07-09T17:49:22-04:00April 2nd, 2020|GIST Education, Patient Support, Webcast|

How to Balance Your Diet During the COVID-19 Pandemic

Nutritional status plays a very important role in the prevention and treatment of contagious and non-contagious diseases. In the frame of a health contingency, the use of strategies that strengthen our nutritional status and immune system is essential.

By |2020-04-03T11:49:23-04:00April 1st, 2020|News, Nutrition, Patient Support|
Go to Top